[The treatment by expanded ex vivo autologous regulatory T-cells CD4+CD25+FoxP3+CD127low restores the balance of immune system in patients with remitting-relapsing multiple sclerosis]. Eliseeva DD, Lifshits GV, Lokhonina AV, Zhdanov DD, Zavalishin IA, Bykovskaya SN Zh Nevrol Psikhiatr Im S S Korsakova. 2016; 116(2. Vyp. 2. Rassejannyyj skleroz):54-62. PMID: 27070362. Abstract CommentRecommendBookmarkWatch